Cited by 23Barrier Structure and Function StudiesCancer Cells and MetastasisCell Adhesion Molecules Research

Nuclear expression of claudin‑3 in human colorectal adenocarcinoma cell lines and tissues

Open access
Tokuhara, Yasunori, Morinishi, Tatsuya, Matsunaga, Toru, Sakai, Manabu, Sakai, Takayoshi, Ohsaki, Hiroyuki, Kadota, Kyuichi, Kushida, Yoshio +2 more·2017·Oncology Letters

Abstract

Claudins are members of a large family of transmembrane proteins, which are essential for the formation of tight junctions and have a significant effect on the biological behavior of tumor progression. Previous studies have demonstrated that several claudins show aberrant expression patterns in numerous types of cancer. The present study investigated the expression and localization of claudin-3 and claudin-7 in human colorectal adenocarcinoma cell lines and tissues. The protein expression levels of claudin-3 and claudin-7 were determined using immunocytochemical and immunohistochemical staining. Claudin-3, but not claudin-7, exhibited nuclear localization in the human colorectal adenocarcinoma Caco-2 and SW620 cell lines. Surgically resected colorectal adenocarcinoma tissue specimens were obtained, and the associations between the expression of claudin-3 or claudin-7 and various clinicopathological parameters were analyzed. The membranous expression rates of claudin-3 and claudin-7 were 58.0 and 50.0%, while their nuclear expression rates were 22.0 and 2.0%, respectively. The membranous expression of claudin-3 and claudin-7 was not associated with any clinicopathological factors, whereas the nuclear expression of claudin-3 was associated with histological type and was significantly increased in colorectal mucinous adenocarcinomas compared with that in well- to moderately-differentiated colorectal adenocarcinomas (P<0.01). However, no associations were observed between the nuclear expression of claudin-7 and any clinicopathological parameter. In conclusion, the nuclear expression of claudin-3 in colorectal mucinous adenocarcinoma may be involved in the biological transformation of tumors. The results from the present study indicated that claudin-3 is an important protein associated with histological type and has potential as a prognostic marker. Although the mechanisms underlying the nuclear localization of claudin-3 in tumorigenesis have not yet been elucidated in detail, the present results indicated the potential of claudin-3 as a histopathological biomarker for colorectal adenocarcinomas.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3892/ol.2017.7281

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Claudin-3 has been shown to control malignancy and metastasis in CRC.

    “Whereas claudin-3 has been shown to control malignancy and metastasis in CRC,52,53 claudin-2 led to a leaky epithelium in tumour tissue.54”

    From PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells (2022) · cites this paper as [52]

    The passage accompanying Table IV (page not supplied) reports that nuclear claudin-3 expression is higher in mucinous colorectal adenocarcinomas and advanced T4 tumors, supporting an association with tumor behavior. It explicitly says further studies are needed to establish whether claudin-3 regulates proliferation or metastasis, so it does not show that claudin-3 controls malignancy and metastasis. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Japanese Society for Cancer of the Colon and Rectum: Japanese Classification of Colorectal Carcinoma. 8th edition, Kanehara, Tokyo, 2013.

Cited by

Sorted by citations

Authors
Tokuhara, Y., Morinishi, T., Matsunaga, T., Sakai, M., Sakai, T., Ohsaki, H., Kadota, K., Kushida, Y., Haba, R., & Hirakawa, E.
Affiliations
  • Laboratory of Pathology, Department of Medical Technology, Kagawa Prefectural University of Health Sciences, Takamatsu, Kagawa 761‑0123, Japan
  • Kagawa University (JP)
  • Osaka Dental University Hospital (JP)
  • The University of Osaka (JP)
  • Kobe University (JP)
Venue
Oncology Letters
Published
2017-10-26
Volume
15
Issue
1
Pages
99-108
ISSN
  • 1792-1074 (ISSN-L)
  • 1792-1082
OpenAlex
W2766438229
Cited by
23
References
1
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2022: 3 · 2021: 6 · 2020: 3 · 2019: 3 · 2018: 2
FWCI
1.09
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Oncology Letters (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (15K15737, 15K08381, 15H02575)
Topics
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
Keywords
claudin-3, claudin-7, colorectal adenocarcinoma, nuclear localization, tight junction proteins, mucinous adenocarcinoma, tumor differentiation, prognostic factors, clinicopathological correlation, Caco-2 cells, SW620 cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review